Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations

Current Cancer Drug Targets

Volumn 1, Issue 2, 2001, Pages 109-119

  Rodriguez Garcia, A ^a   Sanchez Martin, M ^a   Perez Losada J ^a   Perez Mancera P A ^a   Sagreraaparisi, A ^a   Gutierrez Cianca N ^a   Cobaleda, C ^a   Sanchez Garcia I ^a,b  

^a Institute de Biologia Molecular y Cehilar Del Cancer   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; RIBOZYME; TRANSCRIPTION FACTOR;

APOPTOSIS; BIOLOGICAL MODEL; CHEMISTRY; CHIMERA; CHROMOSOME ABERRATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENE FUSION; GENE TRANSLOCATION; GENETICS; HUMAN; NEOPLASM; REVIEW;

APOPTOSIS; ARTIFICIAL GENE FUSION; CHIMERA; CHROMOSOME ABERRATIONS; GENE EXPRESSION REGULATION; HUMANS; MODELS, GENETIC; NEOPLASMS; ONCOGENE PROTEINS, FUSION; RNA, CATALYTIC; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0035427978     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009013334214     Document Type: Article

References (80)

1. Fearon, E.R. Human Cancer Syndromes: Clues to the Origin and Nature of Cancer. Science 1997, 278, 10431050.
2. Mitelman, F.; Mertens, F.; Johansson, B. A. A Breakpoint Map of Recurrent Chromosomal Rearrangements in Human Neoplasia. Nat. Genet. 1997,15, 417-474.
3. Cobaleda, C.; Pérez-Losada, J.; Sânchez-Garcia I. Chromosomal Abnormalities and Tumor Development: from Genes to Therapeutic Mechanism. Bioessays 1998, 20, 922-930.
4. Sânchez-Garcia, I. Consequences of Chromosomal Abnormalities in Tumor Development. Ann. Rev. Genet. 1991,31, 429-453.
5. Rabbitts, T. H. Chromosomal Translocations in Human Cancer. Nature 1994, 372, 143-149.
6. Cleary, M. L.; Sklar, J. Nucleotide Sequence of a t(14;18) Chromosomal Breakpoint in Follicular Lymphoma and Demonstration of a Breakpoint-Cluster Region Near a Transcriptionally Active Locus on Chromosome 18. Proc. Natl. Acad. Sei. USA 1985, 82, 7439-7443.
7. Hatano, M.; Roberts, C. W. M.; Minden, M.; Crist; W. M.; Korsmeyer, S. J. Deregulation of a Homeobox, HOX11, by the t(10;14) in T Cell Leukemia. Science 1991, 253, 79-82.
8. Kennedy, M. A.; Gonzâlez-Sarmiento, R.; Kees, U. R.; Lampert, F.; Dera, N., Boehm T; Rabbitts, T. H. HOX11, a Homeobox-Containing T-CeII Ongogen on Human Chromosome 10q24. Proc. Natl. Acad. Sei. USA 1991, 88, 8900-8904.
9. Lu, M.; Gong, Z.; She, W.; Ho, A. D. The Tcl-3 ProtoOncogene Altered by Chromosomal Translocation in TCell Leukemia Codes for a Homeobox Protein. EMBO J. 1991, 10, 2905-2910.
10. Sânchez-Garcîa, L; Rabbits, T. H. LIM-Domain Proteins in Leukaemia and Development. Semin. Cancer Biol. 1993, 4, 349-358.
11. De Klein, A.; van Kessel, A. G.; Grosveld, G.; Bartram, C. R.; Hagemeijer; A. A Cellular Oncogene is Translocated to The Philadelphia Chromosome in Chronic Myelocytic Leukaemia. Nature 1982, 300, 765767.
12. Sânchez-Garcia, I.; Axelson, H.; Rabbits, T. H. Functional Diversity of L1M Proteins: Amino-Terminal Activation Domains in the Oncogenic Proteins RBTN1 and RBTN2. Oncogene 1995,10, 1301-1306.
13. Adams, J. M., Harris, A. W.; Pinkert, C. A.; Corcoran, L. M.; Alexander, W. S.; Cory, S. Palminter, R. D.; Brinster R. L. The C-Myc Oncogene Driven by Immunoglobulin Enhancers Induces Lymphoid Malignancy in Transgenic Mice. Nature 1985, 318, 533-538.
14. Langdon, W.Y., Harris, A.W. Cory, S.; Adams, J. M. The C-Myc Oncogene Perturbs B Lymphocyte Development in E-mu-Myc Transgenic Mice. Cell 1986, 47, 11-18.
15. Schmidt, E. V.; Pattengale, P. K.; Weir, L.; Leder, P. Transgenic Mice Bearing the Human C-Myc Gene Acticated by an Immunoglubulin Enhancer: A Pre-B Cell Lymphoma Model. Proc. Natl. Acad. Sei. USA 1988,55, 6047-6051.
16. Sânchez-Garcîa, I. Chromosomal Abnormalities, Cancer and Mouse Models: The Critical Role of TranslocationAssociated Genes in Human Cancer. Curr. Genomics 2000, /, 71-80 .
17. Corral, J.; Lavenir, L; Impey, H. I.; Warren, A. J.; Forster, A.; Larson, T. A.; Bell, S.; McKenzie, A. N. J.; King, G.; Rabbitts, T. H. An M11-AF9 fusion gene made by homologous recombination causes acule leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996,85, 853-861.
18. Castellanos, A.; Pintado, B.; Weruaga, E.; Arevalo, R: Lopez, A.; Orfao, A.; Sanchez-Garcia, I. A BCR-AblP190 Fusion Gene Made by Homologous Recombination Causes B-Cell Acute Lymphoblastic Leukemias in Chimeric Mice with Indepence of the Endogenous BCR Product. Blood 1997, 90, 2168-2174.
19. Sânchez-Garcia, I. Consequences of Chromosomal Translocations in Tumor Development. Ann. Rev. Genet. 1997, 31, 429-454.
20. Choo, Y.; Castellanos, A.; Garcia-Hernändez, B.; Sânchez-Garcîa, L; Klug, A. Promoter Specific Activation of Gene Expression Directed by Bacteriophage-Selected Zinc-Fingers. J. Mol. Biol. 1997, 273, 525-532.
21. Choo, Y.; Sänchez-Garcia I.; Klug, A. In Vivo Repression by a Site-Specific DNA-Binding Protein Designed Against an Oncogenic Sequence. Nature 1994, 372, 642-645.
22. Skorski, T.; Nieborowska-Skorska, M.; Nicolaides, N.C.; Szczylik, C.; Iversen, P.; lozzo, R.V.; Zon, G.; Calabretta, B. Supression of Philadelphia1 Leukemia Cell Growth in Mice by BCR-ABL Antisense Oligodeoxinucleotide. Proc. Natl. Acad. Sei. USA 1994, 91, 4504-4508.
23. Garcia-Hernândez, B.; Castellanos, A.; Lopez, A.; Orfao, A.; Sänchez-Garcia, I. Murine Hematopoietic Reconstitution after Tagging and Selection of Retrovirally Transduced Bone Marrow Cells. Proc. Natl. Acad. Sei. USA 1997,94, 13239-13244.
24. Shore, S. K.; Nabissa, P. M.; Reddy, E. P. Ribozymemediated cleavage of BCR-ABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of p210 proteinkinase activity. Oncogene 1993, 8, 3183-3188.
25. Snyder, D. S.; Wu, Y.; Wang, J. L.; Rossi, J. J.; Swiderski, P.; Kaplan, B. E.; Forman, S. J. RibozymeMetiated Inhibition of Bcr-Abl Gene Expression in a Philadelphia Chromosome Positive Cell Line. Blood 1993, 82, 600-605 .
26. Doherty, E. A.; Doudna, J. A. Ribozyme structure and mechanisms. Annu. Rev. Biochem. 2000, 69, 597-615.
27. Liu, F.; Altman, S. Requirements for Cleavage by A Modified Rnase P of a Small Model Substrate. Nucleic Acid. Res. 1996, 24, 2690-2696.
28. Frank, D. N.; Pace, N. R. Ribonuclease P: Unity and Diversity in A tRNA Processing Ribozyme. Annu. Rev. Biochem. 1998, 67, 153-180.
29. Cobaleda, C.; Sänchez-Garcia, I. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: .a novel approach for cancer treatment. Blood 2000, 95, 731-737.
30. Crisell, P.; Thompson, S.; James, W. Inhibition of HIV-1 Replication by Ribozymes that Show Poor Activity In Vitro. Nucleic Acid Res. 1993, 21, 5251-5255.
31. Brenner, M. K. Gene Transfer into Hematopoietic Cells. N. Engl. J. Med. 1996, 335, 337-339.
32. Van Beusechem, V. W.; Valerio, D. Gene Transfer into Hematopoietic Stem Cells of Nonhuman Primates. Human Gene. Ther. 1996, 7, 1649-1668.
33. Anderson, W. F. Human Gene Therapy. Nature 1998, 392, 25-30.
34. Persons, D.; Allay, J. A.; Riberdy, J. M.; Wersto, R .P.; Donahue, R. E:; Sorrentino, B. P.; Nienhuis, A. W. Use of the Green Fluorescent Protein as a Marker to Identify and Track Genetically Modified Hematopoietic Cells. Nature Med. 1998, 4, 1201-1205.
35. Reynolds, P. N.; Feng, M.; Curiel, D. T. Chimeric Viral Vectors - The Best of Both Words? Mol. Med. Today 1999, 5, 25-31.
36. Robbins, P.D.; Tahara, H.; Ghivizzani, S. S. Viral Vectors for Gene Therapy. TIBTECH 1998,16, 35-40.
37. Verma, I. M.; Somia, N. Gene Therapy-Promises, Problems and Prospects. Nature 1997, 389, 239-242.
38. Phillips, K.; Gentry, T.; McCowage, G.; Gilboa, E.; Smith, C. Cell-Surface Markers for Assesing Gene Transfer into Human Hematopoietic Cells. Nature Med. 1996,2, 1154-1156.
39. Dick, J. E.; Magli, M. C.; Huszard, D.; Phillips, R. A.; Bernstein, A. Introduction of A Selectable Gene into Primitive Stem Cells Capable of Long Term Reconstitution of Hematopoietic System of W/Wv Mice. Cell 1985, 42, 71-79.
40. Eglitis, M. A.; Kantoff, P.; Gliboa, E.; Andersen, W. F. Gene Expression in Mice after High Efficiency Retroviral Mediated Gene Transfer. Science 1985, 230, 1395-1398.
41. Keller, G.; Paige, C.; Gliboa, E. & Wagner E.F. Expression of a Foreign Gene in Myeloid and Lymphoid Cells Derived from Multipotent Haematopoietic Precursors. Nature 1985,318, 149-154.
42. Laneuville, P.; Chang, W.; Kamel-Reid, S.; Fauser, A. A.; Dick, J. E. High-Efficiency Gene Transfer and Expression in Normal Human Hematopoietic Cells with Retrovirus Vectors. Blood 1988, 71, 811-814.
43. Yang, Z.; Korman, A. J.; Cooper, J.; Pious, D.; Acolla, R. S.; Mulligan, R. C.; Strominger, J. L. Expression of HLADR Antigen in Human Class II Mutant B-Cell Lines by Double Infection with Retrovirus Vectors. Mol. Cell Biol. 1987, 7, 3923-3928.
44. Wood, P. A.; Herman, G. E.; Chao, C. Y:; O'Brien, W. E.; Beaudet, A. L. Retrovirus Mediated Gene Transfer of A Arginosuccinate Synthetase into Culture Rodent Cells and Human Citrulinemic Fibroblasts. Cold Spring Harb.Symp. Quant. Biol. 1986,57, 1027-1032.
45. Stuhlmann, H.; Cone, R.; Mulligan, R. C.; Jaenisch, R. Introduction of a Selectable Gene into Different Animal Tissue by a Retrovirus Recombinant Vector. Proc. Natl. Acad. Sei. USA 1984,57, 7151.
46. Spencer, H.T.; Sleep, S. E. H.; Rehg, J. E.; Blakley, R. L; Sorrentino, B. P. A Gene Transfer Strategy for Making Bone Marrow Cells Resistant to Trimetrexate. Blood 1996,57, 2579-2587.
47. Allay, J.A.; Persons, D.A.; Galipeau, J.; Riberdy, J.M.; Ashmun, R.A.; Blakley, R.L. & Sorrentino, B. P. In Vivo Selection of Retrovirally Transduced Hematopoietic Stem Cells. Nature Med. 1998, 4, 1136-111143.
48. Corey, C. A.; DeSilva, A. D. Holland, C. A.; Williams, D. A. Serial Transplantation of Methotrexate-Resistant Bone Marrow: Protection of Murine Recipients from Drug Toxicity by Progeny of Transduced Stem Cells. Blood 1990, 75, 337-343.
49. Miller, A. D.; Law, M. F.; Verma, I. M. Generation of Helper-Free Amphotropic Retroviruses that Transduce a Dominant-Acting Methotrexate-Resistant Dihydrofolate Reductase Gene. Mol. Cell Biol. 1985, 5, 431-437.
50. Stead, R.B:; Kwok, W.W.; Storb, R.; Miller, A.D. Canine Model for Gene Therapy: Inefficient Gene Expression in Dogs Reconstituted with Autologous Marrow Infected Retroviral Vectors. Blood 1988, 77, 742-747.
51. Williams, D. A.; Orkin, S. H.; Mulligan, R. C. Retrovirus-Mediated Transfer of Adenosine Deaminase Gene Sequences into Cells in Culture and into Murine Hematopoietic Cells in Vivo. Proc. Natl. Acad. Sei. USA. 1986, 83, 2566-2570.
52. Zhao, R. C. H.; Mclvor, R. S.; Griffin, J. D.; Verfaillie, C. M. Gene Therapy for Chronic Myelogenous Leukemia (CML): A Retroviral Vector That Renders Hematopoietic Progenitors Methotrexate-Resistant and CML Progenitors Functionally Normal and Nontumorigenic In Vivo. Blood 1997, 90, 4687-4698.
53. Sorrentino, B. P.; Brandt, S. J.; Bodine, D.; Gottesman, M.; Pastan, I.; Cline, A.; Nienhuis, A. W. Selection of Drug-Resistant Bone Marrow Cells In Vivo after Retroviral Transfer of Human MDR\. Science 1992, 257, 99-103.
54. Podda, S.; Ward, M.; Himelstein, A.; Richardson, C.; De La Flor-Weiss, E.; Smith, L.; Gottesman, M.; Pastan, I. & Bank, A. Transfer and Expression of the Human Multiple Drug Resistance Gene into Live Mice. Proc. Natl. Acad. Sei. USA 1992, 89, 9676-9680.
55. Eckert, H.-G.; Stockschländer, M.; Just, U.; HegewischBecker, S.; Grez, M.; Uhde, A.; Zander, A.; Ostertag, W.; Baum, C. High-Dose Multidrig Resistane in Primary Human Hematopoietic Progenitor Cells Transduced with Optimized Retroviral Vectors. Blood 1996, 88. 3407-3415.
56. Ward, M.; Richardson, C.; Pioli, P.; Smith, L.; Podda, S.; Goff, S.; Hesdorffer, C.; Bank, A. Transfer and Expression of The Human Multiple Durg Resistance Gene in Human CD34+ Cells. Blood 1994, 84, 1408-1414 .
57. Nolan, G. P.; Fiering, S.; Nicolas, J.-F.; Herzenberg, L. A. Fluorescence-Activated Cell Analysis and Sorting of Viable Mammalian Cells Based on B-D-Galactosidase Activity after Transduction of Escherichia coli LacZ. Proc. Natl. Acad. Sei. USA 1988, 85, 2603-2607.
58. Strair, R. K.; Towle, M.; Heald, P. W.; Smith, B. R. Retroviral Mediated Gene Transfer and Expression of Exogenous Genes in Primary Lymphoid Cells: Assaying for a Viral Transactivatior Activity in Normal and Malignant Cells. Blood 1990, 76, 1201-1208.
59. Strair, R.K.; Towle, M.; Smith, B.R. Retroviral Mediated Gene Transfer into Bone Marrow Progenitor Cells: Use of Beta-Galactosidase as a Selectable Marker. Nucleic Acids Res. 1990,18, 4759-4762.
60. Wilson, J. M.; Jefferson, D. M.; Chowdhury, J. R.; Novikoff, P. M.; Johnston, D. E.; Mulligan, R. C. Retrovirus Mediated Transduction of Adult Hepatocytes. Proc. Natl. Acad. Sei. USA 1988, 85, 3014-3018.
61. Henthorn, P.; Zervos, P.; Raducha, M.; Harris, H.; Kadesch, T. Expression Of Ahuman Placental Alkaline Phosphatase Gene in Transfected Cells: Use as a Reporter for Studies of Gene Expression. Proc. Natl. Acad. Sei. USA 1988, 85, 6342-6346.
62. Ferry, N.; Duplessio, O.; Houssin, D.; Danos, O.; Heard, J.-M. Retroviral Mediated Gene Transfer into Hepatocytes In Vivo. Proc. Natl. Acad. Sei. USA 1991, 88, 8377-8381.
63. Nabel, E.; Plautz, G.; Boyce, F. M.; Stanley, C.; Nabel, G. J. Recombinant Gene Expression In Vivo Within Endothelial Cells of the Arterial Wall. Science 1989, 244, 1342-1344.
64. Nabel, E.; Plautz, G.; Nabel, G. J. Site Specific Gene Expression In Vivo by Direct Gene Transfer into the Arterial Wall. Science 1990, 249, 1285-1288.
65. Price.J.; Turner, D.; Cepko, C. Lineage Analysis in Vertebrate Nervous System by Retrovirus-Mediated Gene Transfer. Proc. Natl. Acad. Sei. USA 1987, 84, 156160.
66. Cheng, L.; Du, C.; Lavau, C.; Chen, S.; Tong, J.; Chen, B.P.; Scollay, R.; Hawley, R.G.; Hill, B. Sustained Gene Expression in Retrovirally Transduced, Engrafting Human Hematopoietic Stem Cells and Their LymphoMyeloid Progeny. Blood 1998, 92, 83-92.
67. Mavilio, F., Ferrari, G.; Rossini, S.; Nobili, N.; Bonini, C.; Casorati, G.; Traversari, C.; Bordignon, C. Peripheral Blood Lymphocytes as Target Cells of Retroviral VectorMediated Gene Transfer. Blood 1994, 83, 1988-1997.
68. Bauer, T. R. Jr.; Hickstein, D. D. Transduction of Human Hematopoietic Cells and Cell Lines Using a Retroviral Vector Containing a Modified Murine CD4 Reporter Gene. Hum. Gene Ther. 1997, 8, 243-252.
69. Pawliuk, R.; Kay, R.; Lansdorp, P.; Humphries, R. K. Selection of Retrovirally Transduced Hematopoietic Cells Using CD24 as a Marker of Gene Transfer. Blood 1994,84, 2868-2877.
70. Conneally, E.; Bardy, P.; Eaves, C. J.; Thomas, T.; Chappel, S.; Shpall, E. J.; Humphries, R. K. Rapid and Efficient Selection of Human Hematopoietic Cells Expressing Murine Heat-Stable Antigen as Indicator of Retroviral-Mediated Gene Transfer. Blood 1996, 87, 456-464.
71. Medin, J.A.; Migita, M.; Pawliuk, R.; Jacobson, S.; Amiri, M.; Kluepfel-Stahl, S.; Brady, R.O.; Humphries, R. K.; Karlsson, S. A Bicistronic Therapeutic Retroviral Vector Enhables Sorting of Transduced CD34+ Cells and Corrects the Enzyme Deficiency in Cells from Gaucher Patients. Blood 1996,87, 1754-1762.
72. Persons, D.; Allay, J. A.; Allay, E. A.; Smeyne, R. J.; Ashmun, R. A.; Sorrentino, B. P.; Nienhuis, A.W. Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene into Murine Hematopoietic Cells Facilitates Scoring and Selection of Transduced Progenitors In Vitro and Identification of Genetically Modidied Cells In Vivo. Blood 1997, 90, 1777-1786.
73. Kafri, T.; Blömer, U.; Peterson, D.A.; Gage, F. H.; Verma, I. M. Sustained Expression Of Genes Delivered Direcly into Liver and Muscle by Lentiviral Vectors. Nat. Genet. 1997, 17, 314-317.
74. Naldini, L.; Blömer, U.; Gallay, P.; Cry, D.; Mulligan, R.; Gage, F. H.; Verma, I. M.; Trono, D. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector. Science 1996, 272, 263-267.
75. Blomer, U.; Naldini, L.; Kafri, Trono, D., T.; Verma, I. M; Gage, F. H. Highly Efficient and Sustained Gene Transfer in Adult Neurons with a Lentivirus Vector. J. Virol. 1997, 71, 6641-6649.
76. Miyoshi, H.; Takahashi, M.; Gage, F. H.; Verma, I. M. Stable and Efficient Gene Transfer into the Retina Using an HIV-Based Lentiviral Vector. Proc. Natl. Acad. Sei. USA 1997,94, 10319-10323.
77. Sutton.R.E.; Wu, H. T. M.; Rigg, R.; Böhnlein, E.; Brown, P. O. Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells. J. Virol. 1998, 72, 5781-5788.
78. Uchida, N.; Sutton, R. E.; Priera, A.; He, D.; Reitsma, M. J.; Chang, W. C.; Veres, G.; Scollay, R.; Weissman, I. L. HIV, but not Murine Leukemia Virus , Vectors Mediate High Efficiency Gene Transfer into Freshly Isolated Gn/Gi Human Hematopoietic Stem Cells. Proc. Natl. Acad. Sei. USA 1998, 95, 11939-11944.
79. Miyoshi, H.; Smith, K. A.; Mosier, D. E.; Verma, I. M.; Torbett, B. E. Transduction of Humancd34+ Cells that Mediate Long-Term Engrafment of NOD/SCID Mice by HIV Vectors. Science 1999, 283, 682-686.
80. Kay, M. A., Glorioso, J. C.; Naldini, L. Viral Vectors for Gene Therapy: The Art of Turning Infectious Agents into Vehicles of Therapeutics. Nature Med. 2001, 7, 3340. .